Abstract | BACKGROUND:
Collagen cross-linking has been reported to be effective in treating progressive keratoconus, and this study aims to evaluate the long-term efficacy of this procedure. DESIGN: Prospective longitudinal interventional study of patients with progressive keratoconus who underwent cross-linking in a tertiary referral hospital. PARTICIPANTS: Thirty-five patients (51 eyes) who underwent cross-linking with a mean follow-up of 14.38 ± 9.36 months (range 6-48) were compared with a control group of 25 fellow eyes that did not undergo the procedure. METHODS: Cross-linking was performed using 0.1% riboflavin (in 20% dextran T500) and ultraviolet A irradiation (370 nm, 3 mW/cm(2) , 30 min). MAIN OUTCOME MEASURES: Maximum keratometry in dioptres, logMAR best spectacle-corrected visual acuity, cylindrical power, manifest refraction spherical equivalent and central corneal thickness. RESULTS: Analysis of the treated group demonstrated a significant flattening of maximum keratometry by 0.96 ± 2.33 dioptres (P = 0.005) and a significant improvement in visual acuity by 0.05 ± 0.13 logMAR (P = 0.04). In the control group, maximum keratometry increased significantly by 0.43 ± 0.85 dioptres (P = 0.05), and visual acuity decreased by mean 0.05 ± 0.14 (P = 0.2). No statistical differences were noted regarding cylindrical power, spherical equivalent or corneal thickness in both groups. CONCLUSIONS:
|
Authors | Deepa Viswanathan, John Males |
Journal | Clinical & experimental ophthalmology
(Clin Exp Ophthalmol)
Vol. 41
Issue 6
Pg. 531-6
(Aug 2013)
ISSN: 1442-9071 [Electronic] Australia |
PMID | 23145528
(Publication Type: Journal Article)
|
Copyright | © 2012 The Authors. Clinical and Experimental Ophthalmology © 2012 Royal Australian and New Zealand College of Ophthalmologists. |
Chemical References |
- Cross-Linking Reagents
- Photosensitizing Agents
- Collagen
- Riboflavin
|
Topics |
- Adolescent
- Adult
- Collagen
(metabolism)
- Corneal Pachymetry
- Corneal Stroma
(metabolism)
- Cross-Linking Reagents
(therapeutic use)
- Disease Progression
- Female
- Humans
- Keratoconus
(diagnosis, drug therapy, metabolism)
- Longitudinal Studies
- Male
- Photosensitizing Agents
(therapeutic use)
- Prospective Studies
- Refraction, Ocular
(physiology)
- Riboflavin
(therapeutic use)
- Ultraviolet Rays
- Visual Acuity
(physiology)
- Young Adult
|